{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:57:43Z","timestamp":1786118263112,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As the worldwide prevalence of obesity increases, more patients with obesity are referred for antireflux surgery (ARS). Although bariatric surgery is typically recommended, at times straightforward ARS is offered. We aimed to compare surgical and patient-reported outcomes among overweight and obese patients undergoing minimally invasive ARS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective cohort study included consecutive patients with BMI\u2009\u2265\u200925\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      who underwent primary elective ARS by an experienced foregut surgeon (September 2016\u2013June 2025). Patients were stratified by BMI: overweight 25\u201330, class I obesity 30\u201335, class II obesity 35\u201340, and class III obesity\u2009\u2265\u200940\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      . Exclusions included prior foregut procedures or non-fundoplication ARS (e.g., magnetic sphincter augmentation). Outcomes of interest were perioperative morbidity, hernia recurrence, midterm quality-of-life\u00a0scores, and patient satisfaction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 338 patients (71.6% female; median age: 65.1 [54.6\u201373.1] years) were stratified into the BMI groups: overweight (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009172, 50.9%), class I (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009125, 36.9%), class II (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200930, 8.9%), and class III (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200911, 3.3%). Intraoperative complication rates (3.5, 4.8, 3.3, and 27.3%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006) and ICU admission rates (1.7, 4, 3.3, and 18.2%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.026) were significantly higher, and early postoperative complications were slightly higher (7.6, 8.8, 6.7, and 27.3%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.153) in the class III obesity group. Follow-up\u2009\u2265\u200912\u00a0months was available for 95\/172 (55.2%), 64\/125 (51.2%), 15\/30 (50%), and 3\/11 (27.3%) patients per group with similar median durations (24\u201336\u00a0months). Objective hiatal hernia recurrence (&gt;\u20092\u00a0cm) was observed in 1 overweight and 2 class-I patients, but no class-II\/III patients. Improved quality-of-life (GERD-HRQL)\u00a0scores and high patient satisfaction, especially in the 25\u201340\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      BMI groups, were reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Minimally invasive ARS provides a favorable safety profile along with gastroesophageal reflux control and improved quality of life for overweight and non-morbidly obese patients. Particularly, straightforward ARS for patients with class II obesity may be considered when limitations on bariatric surgery exist.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00464-026-13263-w","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:26:30Z","timestamp":1786029990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perioperative morbidity and midterm outcomes following antireflux surgery in overweight and obese populations"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3401-8623","authenticated-orcid":false,"given":"Andr\u00e9s R.","family":"Latorre-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8681-968X","authenticated-orcid":false,"given":"Arianna","family":"Vittori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2760-3891","authenticated-orcid":false,"given":"Sumeet K.","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"13263_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5334\/gh.1459","volume":"20","author":"S Mendis","year":"2025","unstructured":"Mendis S, Graham I, Branca F, Collins T, Tukuitonga C, Gunawardane A, Narula J (2025) Alarming rise of obesity: the 4th United Nations high-level meeting on noncommunicable diseases and mental health should advance action to tackle obesity. Glob Heart 20:70","journal-title":"Glob Heart"},{"key":"13263_CR2","doi-asserted-by":"publisher","DOI":"10.15620\/cdc\/159281","author":"SD Emmerich","year":"2024","unstructured":"Emmerich SD, Fryar CD, Stierman B, Ogden CL (2024) Obesity and severe obesity prevalence in adults: United States, August 2021\u2013August 2023. NCHS Data Brief. https:\/\/doi.org\/10.15620\/cdc\/159281","journal-title":"NCHS Data Brief"},{"key":"13263_CR3","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1080\/13696998.2025.2554518","volume":"28","author":"P McEwan","year":"2025","unstructured":"McEwan P, Faurby M, L\u00fcbker C, Padgett T, Toliver JC (2025) The evolving burden of obesity in the US: a novel population-level system dynamics approach. J Med Econ 28:1512\u20131525","journal-title":"J Med Econ"},{"key":"13263_CR4","doi-asserted-by":"publisher","first-page":"1675457","DOI":"10.3389\/fphys.2025.1675457","volume":"16","author":"M Yiqing","year":"2025","unstructured":"Yiqing M, Yangyang Z, Lanshuo H, Wenhao Z, Yixin A, Yingpan Z, Xudong T (2025) Association between body mass index at different levels and risk of gastroesophageal reflux disease: a systematic review with dose-response meta-analysis. Front Physiol 16:1675457","journal-title":"Front Physiol"},{"key":"13263_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.cireng.2022.12.007","volume":"101","author":"A Garc\u00eda Ruiz De Gordejuela","year":"2023","unstructured":"Garc\u00eda Ruiz De Gordejuela A, Ibarzabal Olano A, Petrola Chac\u00f3n CG, Gonz\u00e1lez L\u00f3pez \u00d3 (2023) Obesity related pathophysiological aspects favouring gastroesophageal reflux disease. Cirug\u00eda Espa\u00f1ola (English Edition) 101:S3\u2013S7","journal-title":"Cirug\u00eda Espa\u00f1ola (English Edition)"},{"key":"13263_CR6","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1089\/lap.2018.0395","volume":"28","author":"AC Valezi","year":"2018","unstructured":"Valezi AC, Herbella FAM, Schlottmann F, Patti MG (2018) Gastroesophageal reflux disease in obese patients. J Laparoendosc Adv Surg Tech A 28:949\u2013952","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"13263_CR7","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1053\/j.gastro.2006.12.032","volume":"132","author":"JCY Wu","year":"2007","unstructured":"Wu JCY, Mui LM, Cheung CMY, Chan Y, Sung JJY (2007) Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology 132:883\u2013889","journal-title":"Gastroenterology"},{"key":"13263_CR8","doi-asserted-by":"publisher","first-page":"G335","DOI":"10.1152\/ajpgi.00199.2021","volume":"321","author":"S Paris","year":"2021","unstructured":"Paris S, Ekeanyanwu R, Jiang Y, Davis D, Spechler SJ, Souza RF (2021) Obesity and its effects on the esophageal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 321:G335\u2013G343","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"13263_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","volume":"117","author":"PO Katz","year":"2022","unstructured":"Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ (2022) ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 117:27\u201356","journal-title":"Am J Gastroenterol"},{"key":"13263_CR10","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00464-022-09817-3","volume":"37","author":"BJ Slater","year":"2023","unstructured":"Slater BJ, Collings A, Dirks R, Gould JC, Qureshi AP, Juza R, Rodr\u00edguez-Luna MR, Wunker C, Kohn GP, Kothari S, Carslon E, Worrell S, Abou-Setta AM, Ansari MT, Athanasiadis DI, Daly S, Dimou F, Haskins IN, Hong J, Krishnan K, Lidor A, Litle V, Low D, Petrick A, Soriano IS, Thosani N, Tyberg A, Velanovich V, Vilallonga R, Marks JM (2023) Multi-society consensus conference and guideline on the treatment of gastroesophageal reflux disease (GERD). Surg Endosc 37:781\u2013806","journal-title":"Surg Endosc"},{"key":"13263_CR11","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1007\/s11695-020-04690-2","volume":"30","author":"M Suter","year":"2020","unstructured":"Suter M (2020) Gastroesophageal reflux disease, obesity, and Roux-en-Y gastric bypass: complex relationship\u2014a narrative review. Obes Surg 30:3178\u20133187","journal-title":"Obes Surg"},{"key":"13263_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s40273-015-0302-y","volume":"33","author":"AS Chawla","year":"2015","unstructured":"Chawla AS, Hsiao C-W, Romney MC, Cohen R, Rubino F, Schauer P, Cremieux P (2015) Gap between evidence and patient access: policy implications for bariatric and metabolic surgery in the treatment of obesity and its complications. Pharmacoeconomics 33:629\u2013641","journal-title":"Pharmacoeconomics"},{"key":"13263_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.orcp.2020.07.001","volume":"14","author":"E Luzzolino","year":"2020","unstructured":"Luzzolino E, Kim Y (2020) Barriers impacting an individuals decision to undergo bariatric surgery: a systematic review. Obes Res Clin Pract 14:310\u2013320","journal-title":"Obes Res Clin Pract"},{"key":"13263_CR14","doi-asserted-by":"publisher","first-page":"14272","DOI":"10.3748\/wjg.v20.i39.14272","volume":"20","author":"M Frazzoni","year":"2014","unstructured":"Frazzoni M (2014) Laparoscopic fundoplication for gastroesophageal reflux disease. WJG 20:14272","journal-title":"WJG"},{"key":"13263_CR15","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s004640000392","volume":"15","author":"AR Perez","year":"2001","unstructured":"Perez AR, Moncure AC, Rattner DW (2001) Obesity adversely affects the outcome of antireflux operations. Surg Endosc 15:986\u2013989","journal-title":"Surg Endosc"},{"key":"13263_CR16","doi-asserted-by":"publisher","first-page":"7589408","DOI":"10.1155\/2017\/7589408","volume":"2017","author":"M Schietroma","year":"2017","unstructured":"Schietroma M, Piccione F, Clementi M, Cecilia EM, Sista F, Pessia B, Carlei F, Guadagni S, Amicucci G (2017) Short- and long-term, 11\u201322 years, results after laparoscopic nissen fundoplication in obese versus nonobese patients. J Obes 2017:7589408","journal-title":"J Obes"},{"key":"13263_CR17","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s11605-015-2907-z","volume":"19","author":"S Akimoto","year":"2015","unstructured":"Akimoto S, Nandipati KC, Kapoor H, Yamamoto SR, Pallati PK, Mittal SK (2015) Association of body mass index (BMI) with patterns of fundoplication failure: insights gained. J Gastrointest Surg 19:1943\u20131948","journal-title":"J Gastrointest Surg"},{"key":"13263_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doae117","volume":"38","author":"AR Latorre-Rodr\u00edguez","year":"2025","unstructured":"Latorre-Rodr\u00edguez AR, Rajan A, Mittal SK (2025) Perioperative morbidity after primary hiatal hernia repair increases as hernia size increases. Dis Esophagus 38:doae117","journal-title":"Dis Esophagus"},{"key":"13263_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrad026","volume":"7","author":"C Cullinane","year":"2023","unstructured":"Cullinane C, Fullard A, Croghan SM, Elliott JA, Fleming CA (2023) Effect of obesity on perioperative outcomes following gastrointestinal surgery: meta-analysis. BJS Open 7:zrad026","journal-title":"BJS Open"},{"key":"13263_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S1091-255X(99)80071-7","volume":"3","author":"G Campos","year":"1999","unstructured":"Campos G, Peters JH, DeMeester TR, \u00d6berg S, Crookes PF, Tan S, DeMeester SR, Hagen JA, Bremner CG (1999) Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 3:292\u2013300","journal-title":"J Gastrointest Surg"},{"key":"13263_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1442-2050.2001.00157.x","volume":"14","author":"J Fraser","year":"2001","unstructured":"Fraser J, Watson DI, O\u2019Boyle CJ, Jamieson GG (2001) Obesity and its effect on outcome of laparoscopic Nissen fundoplication. Dis Esophagus 14:50\u201353","journal-title":"Dis Esophagus"},{"key":"13263_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.amjsurg.2014.02.010","volume":"208","author":"DA Telem","year":"2014","unstructured":"Telem DA, Altieri M, Gracia G, Pryor AD (2014) Perioperative outcome of esophageal fundoplication for gastroesophageal reflux disease in obese and morbidly obese patients. Am J Surg 208:163\u2013168","journal-title":"Am J Surg"},{"key":"13263_CR23","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00464-014-3842-x","volume":"29","author":"R-R Luketina","year":"2015","unstructured":"Luketina R-R, Koch OO, K\u00f6hler G, Antoniou SA, Emmanuel K, Pointner R (2015) Obesity does not affect the outcome of laparoscopic antireflux surgery. Surg Endosc 29:1327\u20131333","journal-title":"Surg Endosc"},{"key":"13263_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s00595-017-1579-6","volume":"48","author":"M Hoshino","year":"2018","unstructured":"Hoshino M, Omura N, Yano F, Tsuboi K, Yamamoto SR, Akimoto S, Masuda T, Kashiwagi H, Yanaga K (2018) Effects of the body mass index (BMI) on the surgical outcomes of laparoscopic fundoplication for gastro-esophageal reflux disease: a propensity score-matched analysis. Surg Today 48:236\u2013241","journal-title":"Surg Today"},{"key":"13263_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.surge.2018.05.001","volume":"17","author":"Y Bashir","year":"2019","unstructured":"Bashir Y, Chonchubhair HN, Duggan SN, Memba R, Ain QU, Murphy A, McMahon J, Ridgway PF, Conlon KC (2019) Systematic review and meta-analysis on the effect of obesity on recurrence after laparoscopic anti-reflux surgery. Surgeon 17:107\u2013118","journal-title":"Surgeon"},{"key":"13263_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00464-005-0031-y","volume":"20","author":"M Anvari","year":"2006","unstructured":"Anvari M, Bamehriz F (2006) Outcome of laparoscopic Nissen fundoplication in patients with body mass index \u226535. Surg Endosc 20:230\u2013234","journal-title":"Surg Endosc"},{"key":"13263_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00464-011-1832-9","volume":"26","author":"K Tekin","year":"2012","unstructured":"Tekin K, Toydemir T, Yerdel MA (2012) Is laparoscopic antireflux surgery safe and effective in obese patients? Surg Endosc 26:86\u201395","journal-title":"Surg Endosc"},{"key":"13263_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10388-009-0205-0","volume":"6","author":"K Tsuboi","year":"2009","unstructured":"Tsuboi K, Omura N, Yano F, Kashiwagi H, Kawasaki N, Suzuki Y, Yanaga K (2009) Body mass index has no effect on the results of laparoscopic fundoplication in Japanese patients with reflux esophagitis. Esophagus 6:237\u2013241","journal-title":"Esophagus"},{"key":"13263_CR29","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s00464-003-8118-9","volume":"17","author":"ER Winslow","year":"2003","unstructured":"Winslow ER, Frisella MM, Soper NJ, Klingensmith ME (2003) Obesity does not adversely affect the outcome of laparoscopic antireflux surgery (LARS). Surg Endosc 17:2003\u20132011","journal-title":"Surg Endosc"},{"key":"13263_CR30","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.soard.2025.02.008","volume":"21","author":"J Principe","year":"2025","unstructured":"Principe J, Angeramo CA, Bertona S, Masrur MA, Buxhoeveden R, Schlottmann F (2025) Efficacy of combined sleeve gastrectomy and nissen fundoplication for weight loss and prevention of postoperative gastroesophageal reflux disease in patients with obesity: a systematic review and meta-analysis. Surg Obes Relat Dis 21:829\u2013837","journal-title":"Surg Obes Relat Dis"},{"key":"13263_CR31","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1007\/s11695-025-07865-x","volume":"35","author":"N Sargsyan","year":"2025","unstructured":"Sargsyan N, Ali I, Namgoong C, Das B, Fehervari M, Fadel MG (2025) Gastro-oesophageal reflux disease outcomes following Roux-en-Y gastric bypass surgery in patients with obesity: a systematic review and meta-analysis. Obes Surg 35:2321\u20132332","journal-title":"Obes Surg"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-13263-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-026-13263-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-13263-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:26:31Z","timestamp":1786029991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-026-13263-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":31,"alternative-id":["13263"],"URL":"https:\/\/doi.org\/10.1007\/s00464-026-13263-w","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Within the previous 24\u00a0months, A.L. has served as a consultant for Castle Biosciences Inc.; A.V. has served as a consultant for Castle Biosciences Inc.; S.M. has served as a speaker for Medtronic Inc. and as a consultant for Endostim LLC, and Attract LLC. H.T. has no conflicts of interest or financial ties to disclose. None of these relations influenced the study or the reporting of findings.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}}]}}